CARA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.708 USD | +3.46% |
|
-4.30% | -5.92% |
Chart calendar Cara Therapeutics, Inc.
e7a5673.ZgbnOgVwRMMNYFdIIc2sGTy51lfxl_7KW_6bynzqPE4.FTK2CDIAcJM6FTQgTavGcmjWhQbD2rKYbczSmAreaTcnWdZcKDIDlj4KZw~3aec18c67bfacdd5e615eeac1c91983b
Upcoming events on Cara Therapeutics, Inc.
Past events on Cara Therapeutics, Inc.
| 09/04/2024 06:15 pm | Needham Healthcare Conference |
| 27/03/2024 07:30 pm | Investor Meeting - Key Opinion Leader |
| 05/03/2024 03:00 am | Q4 2023 Earnings Call |
| 05/03/2024 02:31 am | Q4 2023 Earnings Release |
| 22/01/2024 07:00 pm | Business Update Call |
| 30/11/2023 03:00 am | Piper Sandler Healthcare Conference |
| 16/11/2023 01:30 pm | Jefferies London Healthcare Conference |
| 15/11/2023 09:25 pm | Stifel Healthcare Conference |
| 14/11/2023 03:00 am | Q3 2023 Earnings Call |
| 14/11/2023 02:31 am | Q3 2023 Earnings Release |
| 11/09/2023 06:30 pm | H.C. Wainwright Global Investment Conference |
| 14/08/2023 | Stifel Biotech Summer Summit |
| 09/08/2023 05:30 pm | Canaccord Genuity Growth Conference |
| 08/08/2023 02:00 am | Q2 2023 Earnings Call |
| 08/08/2023 01:31 am | Q2 2023 Earnings Release |
| 21/06/2023 | Stifel Boston Conference |
| 09/06/2023 12:30 am | Jefferies Global Healthcare Conference |
| 01/06/2023 09:30 pm | Annual General Meeting |
| 16/05/2023 02:00 am | Q1 2023 Earnings Call |
| 16/05/2023 01:31 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 19,9 20,1 -1.27% | 135 65,7 105.51% | 23,0 28,8 -20.04% | 41,9 53,5 -21.76% | 21,0 27,5 -23.72% | 5,59 |
|
EBITDA Million USD | Released Forecast Spread | -111 -109 -1.86% | 5,59 -98,2 105.7% | -88,8 -74,9 -18.6% | -87,3 -75,1 -16.3% | 0,00 -77,9 - | -58,3 |
|
EBIT Million USD | Released Forecast Spread | -112 -113 1.23% | 5,39 -61,2 108.8% | -89,1 -80,2 -11.07% | -87,5 -75,4 -16.17% | -121 -113 -7.3% | -64,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -107 -110 2.86% | 7,72 -46,9 116.44% | -88,4 -87,3 -1.28% | -85,5 -74,5 -14.7% | -119 -106 -11.7% | -63,6 |
|
Net income Million USD | Released Forecast Spread | -106 -108 1.72% | 8,41 -53,3 115.78% | -88,4 -76,6 -15.4% | -85,5 -74,5 -14.7% | -119 -106 -11.7% | -63,6 |
|
EPS USD | Released Forecast Spread | -2,49 -2,54 1.97% | 0,18 -1,31 113.71% | -1,74 -1,54 -12.99% | -1,59 -1,36 -16.63% | -2,19 -1,96 -11.73% | -1,09 |
| Announcement Date | 27/02/20 | 25/02/21 | 01/03/22 | 06/03/23 | 04/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,82 1,25 -34.32% | 4,79 2,26 111.93% | 23,0 21,0 9.36% | 10,8 8,86 22.11% | 3,26 14,5 -77.51% | 6,17 4,98 23.75% | 6,93 6,70 3.55% | 4,87 11,1 -56.17% | 3,00 9,13 -67.11% | 1,69 | 1,44 | 1,34 | 1,11 | 1,20 |
|
EBITDA Million USD | Released Forecast Spread | -33,5 -26,5 -26.13% | -27,8 -25,1 -10.89% | -4,41 -13,0 66.07% | -23,8 -23,4 -1.64% | -31,2 -19,1 -64.02% | -27,6 -30,2 8.51% | -32,3 -29,7 -8.87% | -28,8 -28,5 -1.19% | 10,8 | -22,2 | -12,9 | -11,7 | -11,5 | |
|
EBIT Million USD | Released Forecast Spread | -33,5 -27,6 -21.47% | -27,9 -30,8 9.27% | -4,47 -14,5 69.09% | -23,8 -23,6 -0.99% | -31,3 -19,3 -62.63% | -27,7 -29,4 5.8% | -32,3 -30,7 -5.51% | -28,9 -28,4 -1.63% | -32,6 -24,2 -34.96% | -21,6 | -13,6 | -12,6 | -13,8 | -16,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,4 -28,0 -19.38% | -27,7 -33,3 16.65% | -4,21 -14,0 69.99% | -23,2 -24,0 3.6% | -30,3 -19,2 -58.22% | -26,7 -28,6 6.76% | -31,5 -29,8 -5.81% | -28,0 -29,3 4.37% | -32,3 -19,9 -62.28% | -21,6 | -13,9 | -13,3 | -14,8 | -16,2 |
|
Net income Million USD | Released Forecast Spread | -33,4 -28,0 -19.38% | -27,7 -33,3 16.65% | -4,21 -14,0 69.99% | -23,2 -24,0 3.6% | -30,3 -19,2 -58.22% | -26,7 -28,6 6.76% | -31,5 -29,8 -5.81% | -28,0 -28,1 0.22% | -32,3 -19,9 -62.28% | -21,6 | -13,9 | -13,3 | -14,8 | -16,2 |
|
EPS USD | Released Forecast Spread | -0,63 -0,52 -20.38% | -0,52 -0,62 15.67% | -0,08 -0,26 68.98% | -0,43 -0,44 1.39% | -0,56 -0,36 -57.41% | -0,49 -0,52 5.57% | -0,58 -0,54 -7.65% | -0,52 -0,51 -2.61% | -0,59 -0,37 -61.64% | -0,39 | -0,25 | -0,22 | -0,24 | -0,29 |
| Announcement Date | 01/03/22 | 09/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 15/05/23 | 07/08/23 | 13/11/23 | 04/03/24 | - | - | - | - | - |
More events
Past sector events for Cara Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CARA Stock
- Calendar Cara Therapeutics, Inc.
